fraud

Summary

Summary: Exploitation through misrepresentation of the facts or concealment of the purposes of the exploiter.

Top Publications

  1. ncbi Whistleblower-initiated enforcement actions against health care fraud and abuse in the United States, 1996 to 2005
    Aaron S Kesselheim
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Intern Med 149:342-9. 2008
  2. ncbi Retractions in the scientific literature: do authors deliberately commit research fraud?
    R Grant Steen
    Medical Communications Consultants LLC, 103 Van Doren Place, Chapel Hill, NC 27517, USA
    J Med Ethics 37:113-7. 2011
  3. pmc The global threat of counterfeit drugs: why industry and governments must communicate the dangers
    Robert Cockburn
    The Times, London, United Kingdom
    PLoS Med 2:e100. 2005
  4. ncbi Misinformation in the medical literature: what role do error and fraud play?
    R Grant Steen
    Medical Communications Consultants, LLC, 103 Van Doren Place, Chapel Hill, NC 27517, USA
    J Med Ethics 37:498-503. 2011
  5. ncbi Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry
    Camilla Ricci
    Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK
    Anal Chim Acta 623:178-86. 2008
  6. ncbi Off-label or off-limits?
    Mark Ratner
    FDC Windhover
    Nat Biotechnol 26:867-75. 2008
  7. ncbi Detecting hospital fraud and claim abuse through diabetic outpatient services
    Fen May Liou
    Graduate Institute of Business Management, Yuanpei University Hsinchu, 306, Yuanpei St, Hsin Chu 300, Taiwan
    Health Care Manag Sci 11:353-8. 2008
  8. ncbi Health care fraud and abuse
    P E Kalb
    Sidley and Austin, Washington, DC, USA
    JAMA 282:1163-8. 1999
  9. ncbi Science fraud: from patchwork mouse to patchwork data
    Gerald Weissmann
    FASEB J 20:587-90. 2006
  10. pmc WHO launches taskforce to fight counterfeit drugs
    William Burns
    Bull World Health Organ 84:689-90. 2006

Detail Information

Publications214 found, 100 shown here

  1. ncbi Whistleblower-initiated enforcement actions against health care fraud and abuse in the United States, 1996 to 2005
    Aaron S Kesselheim
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Intern Med 149:342-9. 2008
    Federal regulators have aggressively prosecuted health care fraud since the early 1990s, leading to billions of dollars in financial recoveries...
  2. ncbi Retractions in the scientific literature: do authors deliberately commit research fraud?
    R Grant Steen
    Medical Communications Consultants LLC, 103 Van Doren Place, Chapel Hill, NC 27517, USA
    J Med Ethics 37:113-7. 2011
    Papers retracted for fraud (data fabrication or data falsification) may represent a deliberate effort to deceive, a motivation fundamentally different from papers retracted for error...
  3. pmc The global threat of counterfeit drugs: why industry and governments must communicate the dangers
    Robert Cockburn
    The Times, London, United Kingdom
    PLoS Med 2:e100. 2005
  4. ncbi Misinformation in the medical literature: what role do error and fraud play?
    R Grant Steen
    Medical Communications Consultants, LLC, 103 Van Doren Place, Chapel Hill, NC 27517, USA
    J Med Ethics 37:498-503. 2011
    ..Still, one-quarter of retracted papers are fraudulent, and misinformation may also arise through fraud. This paper hypothesises that error and fraud are the main sources of misinformation and that error is more common ..
  5. ncbi Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry
    Camilla Ricci
    Department of Chemical Engineering, Imperial College London, London SW7 2AZ, UK
    Anal Chim Acta 623:178-86. 2008
    ..The applicability of a compact and robust portable Raman spectrometer (TruScan) for the in situ chemical identification of counterfeit tablets is reported...
  6. ncbi Off-label or off-limits?
    Mark Ratner
    FDC Windhover
    Nat Biotechnol 26:867-75. 2008
  7. ncbi Detecting hospital fraud and claim abuse through diabetic outpatient services
    Fen May Liou
    Graduate Institute of Business Management, Yuanpei University Hsinchu, 306, Yuanpei St, Hsin Chu 300, Taiwan
    Health Care Manag Sci 11:353-8. 2008
    ..While all three are quite accurate, the classification tree model performs the best with an overall correct identification rate of 99%. It is followed by the neural network (96%) and the logistic regression model (92%)...
  8. ncbi Health care fraud and abuse
    P E Kalb
    Sidley and Austin, Washington, DC, USA
    JAMA 282:1163-8. 1999
    In recent years, health care fraud and abuse have become major issues, in part because of the rising cost of health care, industry consolidation, the emergence of private "whistle-blowers," and a change in the concept of fraud to include ..
  9. ncbi Science fraud: from patchwork mouse to patchwork data
    Gerald Weissmann
    FASEB J 20:587-90. 2006
  10. pmc WHO launches taskforce to fight counterfeit drugs
    William Burns
    Bull World Health Organ 84:689-90. 2006
  11. ncbi Counterfeit pharmaceuticals: current status and future projections
    Albert I Wertheimer
    Center for Pharmaceutical Health Services Research, Temple University, Philadelphia, PA 19140, USA
    J Am Pharm Assoc (2003) 43:710-7; quiz 717-8. 2003
    ..To examine the problem of counterfeit drugs and its effects around the world, to consider the likely directions the problem will take, and to propose options for controlling or mitigating the problem...
  12. pmc Manslaughter by fake artesunate in Asia--will Africa be next?
    Paul N Newton
    Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom
    PLoS Med 3:e197. 2006
  13. ncbi Counterfeit pharmaceuticals: murder by medicine
    Peter Aldhous
    Nature 434:132-6. 2005
  14. ncbi The effects of the fraud and abuse enforcement program under the National Health Insurance program in Korea
    HeeChung Kang
    Health Insurance Review and Assessment Policy Institute, Health Insurance Review and Assessment Service, Republic of Korea
    Health Policy 95:41-9. 2010
    To examine the general deterrence effect of the Korean government's fraud and abuse enforcement program on medical clinics in the country...
  15. ncbi Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia
    Mohiuddin Hussain Khan
    Department of Drug Management and Policy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan
    Trop Med Int Health 15:639-44. 2010
    ..To assess the prevalence of counterfeit anthelminthic medicines in Cambodia, and to determine influential factors...
  16. ncbi Detecting Medicare abuse
    David Becker
    University of California, Berkeley, CA 94720, USA
    J Health Econ 24:189-210. 2005
    ..claims data linked with social security death records, hospital characteristics, and state/year-level anti-fraud enforcement efforts...
  17. ncbi Tackling corruption in the pharmaceutical systems worldwide with courage and conviction
    J C Cohen
    Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada
    Clin Pharmacol Ther 81:445-9. 2007
    ..are caused by a number of variables including poverty, high drug prices, poor health infrastructure, and fraud and corruption--the latter being the subject of this article...
  18. ncbi The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials
    M Buyse
    International Institute for Drug Development, Brussels, and Limburgs Universitair Centrum, Diepenbeek, Belgium
    Stat Med 18:3435-51. 1999
    Recent cases of fraud in clinical trials have attracted considerable media attention, but relatively little reaction from the biostatistical community...
  19. ncbi Food forensics: using DNA technology to combat misdescription and fraud
    Mark Woolfe
    Food Labelling and Standards Division, Food Standards Agency, Aviation House, 125 Kingsway, London, WC2B 6NH, UK
    Trends Biotechnol 22:222-6. 2004
  20. ncbi Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation
    Leonard Nyadong
    School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
    Anal Chem 79:2150-7. 2007
    ..Of particular concern was the positive detection of artesunate traces in the surface of one of the samples, which we quantified with standard chromatographic techniques...
  21. ncbi Counterfeit drugs
    Paul M Rudolf
    Food and Drug Administration, Rockville, MD, USA
    N Engl J Med 350:1384-6. 2004
  22. ncbi Counterfeit artesunate antimalarials in southeast Asia
    Paul N Newton
    Lancet 362:169. 2003
  23. ncbi Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials
    A M Dondorp
    Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Trop Med Int Health 9:1241-6. 2004
    ..To assess the prevalence of counterfeit antimalarial drugs in Southeast (SE) Asia...
  24. ncbi Antidepressants are sold as antiretrovirals in DR Congo
    Khabir Ahmad
    Lancet 363:713. 2004
  25. ncbi Substandard medicines in resource-poor settings: a problem that can no longer be ignored
    J M Caudron
    Medecins Sans Frontieres, Geneva, Switzerland, and AEDES Fondation, Brussels, Belgium
    Trop Med Int Health 13:1062-72. 2008
    ..Governments in rich countries should not tolerate the export of substandard pharmaceutical products to poor countries, while developing country governments should improve their ability to detect substandard medicines...
  26. ncbi Emerging non-invasive Raman methods in process control and forensic applications
    Neil A MacLeod
    Central Laser Facility, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0QX, UK
    Pharm Res 25:2205-15. 2008
    ....
  27. ncbi Scientific misconduct. Researcher faces prison for fraud in NIH grant applications and papers
    Eli Kintisch
    Science 307:1851. 2005
  28. ncbi Human cloning and embryonic stem cell research after Seoul: examining exploitation, fraud and ethical problems in the research. Testimony of Richard M. Doerflinger
    Richard M Doerflinger
    Natl Cathol Bioeth Q 6:339-50. 2006
  29. ncbi Counterfeit and substandard antimalarial drugs in Cambodia
    C T Lon
    National Center for Parasitology, Entomology and Malaria Control, 372 Boulevard Monivong, Phnom Penh, Cambodia
    Trans R Soc Trop Med Hyg 100:1019-24. 2006
    ..Appropriate strategies need to be developed and implemented by relevant government agencies and stakeholders to strengthen drug quality assurance and control systems in the country...
  30. pmc Murder by fake drugs
    Paul N Newton
    BMJ 324:800-1. 2002
  31. ncbi Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic
    Albert I Wertheimer
    Temple University, School of Pharmacy, 3307 No Broad Street, Philadelphia, PA 19140, USA
    Res Social Adm Pharm 5:4-16. 2009
    ..Counterfeiting and the sale of substandard pharmaceutical products can no longer be ignored. At 10% of global trade, counterfeiting is affecting many countries, causing serious downstream expenses and resource shortages...
  32. ncbi Fraud, errors and gamesmanship in experimental toxicology
    Iain F H Purchase
    University of Manchester, Oxford Road, Manchester M13 9PT, UK
    Toxicology 202:1-20. 2004
    ..The main casualty from fraud, errors and gamesmanship is the perceived status of science itself...
  33. pmc India agrees to help Nigeria tackle the import of fake drugs
    Abiodun Raufu
    BMJ 326:1234. 2003
  34. pmc Drug regulators study global treaty to tackle counterfeit drugs
    Liza Gibson
    BMJ 328:486. 2004
  35. ncbi A right to no meaningful review under the due process clause: the aftermath of judicial deference to the federal administrative agencies
    Ruqaiijah A Yearby
    Loyola University Chicago School of Law, USA
    Health Matrix Clevel 16:723-83. 2006
  36. ncbi Fixing past mistakes. Answers to questions about reviews, refunds, disclosures
    T Jeffrey Fitzgerald
    Faegre and Benson, LLP, Denver, USA
    MGMA Connex 3:38-43, 1. 2003
    ..Its response has a significant impact on how the charges are resolved. A group and its providers can come under fraud and abuse investigations, whistle-blower allegations and Medicare payment reviews...
  37. ncbi Tenet, HealthSouth clear some legal woes
    Vince Galloro
    Mod Healthc 36:17. 2006
  38. ncbi Secondary payer predicament. U.S. Justice Department probes insurers that billed Medicare as primary payer
    Mark Taylor
    Mod Healthc 33:16-7. 2003
  39. ncbi HealthSouth avoids charges
    Joseph Mantone
    Mod Healthc 36:7. 2006
  40. ncbi Beyond the anti-kickback statute: new entities, new theories in healthcare fraud prosecutions
    James G Sheehan
    Saint Louis University School of Law, USA
    J Health Law 40:167-203. 2007
    The authors analyze existing and developing trends in healthcare fraud litigation. They first review the traditional use of the Medicare-Medicaid Anti-Kickback Statute to prosecute such fraudulent activity...
  41. ncbi Justice sues ex-lawyer for Tenet
    Vince Galloro
    Mod Healthc 37:16. 2007
  42. ncbi Obtaining advance beneficiary notices for Medicare physician providers
    Darren Carter
    Provistas, Incorporated, 12 Dongan Place, Suite 203, New York, NY 10040 1592, USA
    J Med Pract Manage 19:10-8. 2003
    ..The author also presents special applications of the ABN regulations as they apply to the EMTALA rules, anti-kickback, and other statutes. Samples of the official ABN forms are illustrated...
  43. ncbi Identifying barriers to billing compliance
    Daniel P Lorence
    Pennsylvania State University, University Park, PA, USA
    J Health Care Finance 30:49-64. 2003
    Programs designed toward the control of health care fraud are leading to increasingly aggressive enforcement and prosecutorial efforts by federal regulators, related to over-reimbursement for service providers...
  44. ncbi Being aware of fraud and abuse is still critically important
    Carolyn J Humphrey
    Home Healthc Nurse 21:507. 2003
  45. ncbi Observation services present compliance challenges
    Sue Prophet-Bowman
    J AHIMA 74:60-5. 2003
  46. ncbi Managing board relationships in tough times
    Kimberly Commins
    Hall, Render, Killian, Heath and Lyman, PSC, Troy, USA
    Mich Health Hosp 39:56-7. 2003
    ....
  47. ncbi OASIS coding, your license, and your reputation
    Elizabeth A Madigan
    Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH 44106 4904, USA
    Home Healthc Nurse 24:190. 2006
  48. ncbi Fraud and fiduciary liability
    Brian Ray Hodge
    Lacquer, Urban, Clifford and Hodge, LLP, Pasadena, California, USA
    Empl Benefits J 28:53-61. 2003
    ..brokers and promoters selling fraudulent policies; plans large enough to be self-insured face greater risks of fraud by providers and participants misrepresenting claims...
  49. ncbi Picking up the tab. Healthcare chains put the past behind them, resolving past unpleasantries in order to make a clean start in the new year
    Vince Galloro
    Mod Healthc 35:6-7, 1. 2005
    ..Peter Urbanowicz, left, said his company's moves show "the real progress we are making to put our legal challenges ... behind us"...
  50. ncbi Are you of good report?
    Shelley R Slade
    Vogel and Slade, LLP, Washington, DC, USA
    Healthc Financ Manage 58:38-40. 2004
    ..Past Medicare credit balance reports may come back to haunt you as current federal enforcement activities indicate they could easily fall under False Claims Act scrutiny...
  51. ncbi Why should your practice perform compliance audits based on the latest OIG Work Plan?
    Marilyn Hammon
    J Okla State Med Assoc 98:95-7. 2005
    ....
  52. ncbi Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution
    David M Studdert
    Harvard School of Public Health, Boston, USA
    N Engl J Med 351:1891-900. 2004
  53. ncbi False claims recoveries down. Experts: 2006 figure understates feds' determination
    Gregg Blesch
    Mod Healthc 37:16. 2007
  54. ncbi The False Claims Act: the courts move toward a rule of reason
    Michael M Mustokoff
    Partner, Duane Morris, LLP, One Liberty Place, Philadelphia, PA 19103 7396, USA
    J Med Pract Manage 20:317-22. 2005
    ..It indicates the limitations that are imposed on prosecutors, as well as the liability that providers do incur under current statues...
  55. ncbi The False Claims Acts & Qui Tam lawsuits
    Harvey M Tettlebaum
    Husch and Eppenberger LLC, Jefferson City, Missouri, USA
    Mo Med 104:466-9. 2007
  56. ncbi Physician joint ventures: new opportunities and risks
    Jeremy N Miller
    Miller Health Law Group, APLC, 2029 Century Park East, Third Floor, Los Angeles, CA 90067, USA
    J Med Pract Manage 19:292-5. 2004
    ..These regulations have now been clarified leading to a resurgent interest in these arrangements. This article outlines the business principles, control issues, legal setting, and the various modalities for joint venturing...
  57. ncbi When Medicare auditors decide it's time for a check-up
    Bruce A Levy
    N J Med 99:33-7. 2002
  58. ncbi Apria, Tenet settle cases
    Joseph Mantone
    Mod Healthc 35:18. 2005
  59. ncbi The deficit reduction act of 2005: policy, politics, and impact on radiologists
    James W Moser
    American College of Radiology, Reston, VA 20191, USA
    J Am Coll Radiol 3:744-50. 2006
    ..Although the DRA cuts payments for certain imaging services, it does nothing to control utilization, which is the prime mover driving spending...
  60. ncbi Make sense of wound care billing: turn your cents into reimbursement dollars
    Deanna M Vargo
    Department of Ambulatory Care Wound Care, Summa Health System, Barberton Citizens Hospital, Barberton, Ohio 44203, USA
    J Wound Ostomy Continence Nurs 35:186-96; quiz 197-8. 2008
    ..Therefore, investing the time to check the site for the latest updates can make a critical difference in your success with reimbursement for wound care services...
  61. ncbi Ethical lawyering in the gray areas: health care fraud and abuse
    Joan H Krause
    University of Houston Law Center and Health Law and Policy Institute, Houston, TX, USA
    J Law Med Ethics 34:121-5. 2006
  62. ncbi Blaming the messenger. Ernst & Young under fire for alleged bad billing advice
    Mark Taylor
    Mod Healthc 34:18-9. 2004
  63. ncbi Tenet wades through legal mess. $215 million settlement reached; jury deliberates
    Vince Galloro
    Mod Healthc 36:10. 2006
  64. ncbi False Claims Act applies to local government
    G Christopher Kelly
    Emerg Med Serv 32:114. 2003
  65. ncbi Crafting risk-free vendor contracts
    Ari J Markenson
    Epstein Becker and Green, New York City, USA
    Provider 29:75-7. 2003
  66. ncbi Florida couple admits using phony treatment to attract clients
    Carol Lewis
    FDA Consum 36:38-9. 2002
  67. ncbi Regional variation in medical systems data: influences on upcoding
    Daniel P Lorence
    Department of Health Policy and Administration, The Pennsylvania State University, University Park 16802, USA
    J Med Syst 26:369-81. 2002
    ..We find significant variation in influence across practice settings and managed care markets. Ramifications for reimbursement assessment are discussed...
  68. ncbi Echoing down from Wall St. Proposed new accounting standards could bring new guidelines for not-for-profits; conflicts between boards, CFOs could result. Merck, Allegheny, HBO & Co
    Mary Chris Jaklevic
    Mod Healthc 32:8-9, 16, 3. 2002
    ..The healthcare industry, which has been trying to scrub clean its own image, is no stranger to the kind of scandals plaguing other industries...
  69. ncbi Trustee workbook 3. Effective governance after Enron and AHERF
    James E Orlikoff
    Trustee 55:15-8. 2002
    ..The Enron bankruptcy will certainly result in lawsuits against its board and directors and has embarrassed board members profoundly...
  70. ncbi The emperor has no clothes: examining the employee exception to the anti-referral laws
    S O Scheutzow
    Ulmer and Berne LLP, Cleveland, OH, USA
    J Health Law 34:21-45. 2001
    ..Consequently, she asserts that this exception should be repealed...
  71. ncbi False Claims Act: failure to seek legal advice not a violation of the FCA
    Jeanne Cavanaugh
    J Law Med Ethics 30:318-9. 2002
  72. ncbi Using the OIG model compliance programs to fight fraud
    Jeffrey A Lovitky
    Ahern and Associates, Department of Health Systems Management, Rush University, Chicago, Illinois, USA
    Healthc Financ Manage 56:64-8. 2002
    ..Using these models as guides, healthcare organizations should be better able to avoid the possibility of fraud and abuse within their organizations.
  73. ncbi The government, the legislature and the judiciary--working towards remedying the problems with the civil False Claims Act: where do we go from here?
    R A McClain
    Piper, Marbury, Rudnick and Wolfe, Chicago, USA
    Ann Health Law 10:191-243. 2001
    ..The article explores the use and effectiveness of the False Claims Act to target fraud and other abuses in the health care system...
  74. ncbi Payment due. Report: CMS slacker for not collecting millions
    Mark Taylor
    Mod Healthc 32:4, 14. 2002
  75. ncbi "This might sting a bit": policing skin care in nursing facilities by litigating fraud
    Michael Stockham
    Cornell Law Rev 87:1041-77. 2002
  76. ncbi Are you committing health care fraud under the False Claims Act? The answer may not be as simple as you think
    Michael K Goldberg
    Goldberg and Frankenstein, LLC, 222 South Riverside Plaza, Suite 810, Chicago, IL 60606, USA
    J Med Pract Manage 17:206-9. 2002
    Health care fraud has a significant financial effect on the operations of the American health care system...
  77. ncbi Corporate integrity agreements: making the best of a tough situation
    Robert B Ramsey
    Healthcare Group of Buchanan Ingersoil, Pittsburgh, Pennsylvania, USA
    Healthc Financ Manage 56:58-62. 2002
    ..are entering into corporate integrity agreements as part of settlements with the Federal government in fraud-and-abuse cases...
  78. ncbi The impact of gaining provider status in the Medicare program. What all dietetics professionals need to know
    Ellen Pritchett
    J Am Diet Assoc 102:480-2. 2002
  79. ncbi Nursing homes face quality-of-care scrutiny under the False Claims Act
    B S Landsberg
    Litigation and Employment Business Unit, Manatt, Phelps and Phillips, LLP, Los Angeles, California, USA
    Healthc Financ Manage 55:54-8. 2001
    ..In a recent case, however, a Federal judge refused to grant the defendant facility's motion to dismiss and permitted the government's case to proceed...
  80. ncbi Healthcare fraud probes have hospitals ahead of the game
    Vince Galloro
    Mod Healthc 32:8-9. 2002
  81. ncbi Quality-of-care issues can create False Claims Act exposure
    Shelley R Slade
    Healthc Financ Manage 56:78-80. 2002
    ..Providers can be fined triple the government's payment if they are found in violation of the False Claims Act. Providers should be aware of knowing violations of quality standards that could lead to False Claims Act exposure...
  82. ncbi The other shoe drops. Barbakow, already set to lose chairman's seat, out as Tenet's CEO; shareholders, analyst call for outsider as his replacement
    Vince Galloro
    Mod Healthc 33:4-5, 16, 1. 2003
    ..stepped down last week from the company he headed during a period of glowing prosperity. But as he departs, Tenet is surrounded by a tempest similar to the one that led to his hiring...
  83. ncbi CMS rebuked on DME. Inspector general report finds 28.9% error rate on claims
    Gregg Blesch
    Mod Healthc 38:20. 2008
  84. ncbi The uncivil war against health care fraud. Who will be excluded next? Part. I
    Marc E Overlock
    Tennessee Medical Foundation, USA
    Tenn Med 96:227-8. 2003
  85. ncbi Clinical trials face heightened scrutiny as science and commerce appear to merge
    Alvin J Lorman
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, USA
    J Biolaw Bus 4:23-32. 2001
    ..The risk of increased government involvement includes criminal prosecution of physicians for failing to follow the rules, as an innovative case in California demonstrates...
  86. ncbi Monitoring improper Medicare payments. New CMS programs build on OIG methods to report errors
    Rita A Scichilone
    J AHIMA 74:70-3. 2003
  87. ncbi Fraud flurry. No connection seen in recent moves by government
    Mark Taylor
    Mod Healthc 33:20, 22. 2003
  88. ncbi Consultant relationships may pose liability risk
    Gabriel L Imperato
    Healthc Financ Manage 57:72-5. 2003
    ..Providers that contract with attorneys, accountants, payment experts, and/or other third-party consultants need to monitor these relationships on an ongoing basis...
  89. ncbi Medicare cost controls and program compliance: the rationale of physician claims edits
    Darren Carter
    J Med Pract Manage 18:115-9. 2002
    ..Many resources are available to aid physicians, including computerized tools, new CMS initiatives, and Internet materials...
  90. ncbi A question of integrity. Federal prosecutors question Tenet's compliance with integrity agreement in a $323 million False Claims Act lawsuit
    Mark Taylor
    Mod Healthc 33:6-7, 16, 1. 2003
    ..The False Claims Act suit alleges Tenet illegally submitted thousands of false claims to maximize revenue. Lawyer Michael Ruggio says Tenet's troubles are far from over...
  91. ncbi Medicare fraud-busters target patient transfer reporting
    Stephen G Sozio
    Trustee 55:46-7. 2002
  92. ncbi Achieving compliance with medical call centers
    William D Darling
    Healthc Financ Manage 56:82-6. 2002
    ..A provider may not escape responsibility for compliance by contracting with call-center vendors. Providers and call-center vendors should work together to understand and comply with relevant statutes...
  93. ncbi Practical considerations for conducting effective billing audits
    Robert F Bacon
    Office of Billing Compliance, University of Pennsylvania, Health System, Philadelphia, Pennsylvania, USA
    Healthc Financ Manage 56:36-9. 2002
    ..regulations, especially with the increased vigilance by the HHS Office of Inspector General (OIG) in investigating fraud and abuse...
  94. ncbi Physicians' reliance on specialists, therapists, and vendors when prescribing therapies and durable medical equipment for children with special health care needs
    R C Sneed
    Department of Pediatrics, Children s Rehabilitation Center, University of Mississippi Medical Center, Jackson, MS 39216 4505, USA
    Pediatrics 107:1283-90. 2001
    ..To protect themselves and their patients from fraud and inappropriate prescriptions and medical management, pediatricians must become increasingly conscientious about ..
  95. pmc The role of the FDA in the effort against AIDS
    F E Young
    Office of Public Affairs, Rockville, MD 20857
    Public Health Rep 103:242-5. 1988
    ..worked with other authorities to move against quack AIDS products and to educate the public concerning this health fraud.FDA hopes that through all these efforts it can help researchers in government, academia, and industry advance the ..
  96. ncbi Changing social policy: Grassroots to legislation
    Liz Lemiska
    Middlesex Hospital, Middletown, Connecticut, USA
    J Wound Ostomy Continence Nurs 29:149-63. 2002
    ..vie to get the most for their health care dollars, federal and state governments attempt to mediate, prevent fraud and abuse, and protect all parties involved...
  97. ncbi Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial
    M R Melamed
    Department of Pathology, New York Medical College, Valhalla 10595, USA
    Acta Cytol 42:69-75. 1998
    ..the medical profession itself, which must recognize the following: (a) Resources are finite; (b) Elimination of fraud, abuse and waste is not enough to bring health care expenditures down to levels considered acceptable to ..
  98. ncbi Interventional pain management at crossroads: the perfect storm brewing for a new decade of challenges
    Laxmaiah Manchikanti
    Pain Management Center of Paducah, Paducah, KY, USA
    Pain Physician 13:E111-40. 2010
    ..Numerous factors contribute to increasing health care costs. They include administrative costs, waste, abuse, and fraud. It has been claimed the U.S. health care system wastes up to $800 billion a year...
  99. ncbi Neonatal jaundice and scientific fraud in 1804
    T W R Hansen
    Department of Pediatrics, Rikshospitalet, University of Oslo, Norway
    Acta Paediatr 91:1135-8. 2002
    ..Unfortunately, university records from that period are incomplete, and it is not clear what, if anything, was done about the matter. Baumes had a very distinguished career and achieved a great reputation as both a teacher and clinician...
  100. ncbi Clinical forensic medicine and its main fields of activity from the foundation of the German Society of Legal Medicine until today
    S Pollak
    Institute of Legal Medicine, University of Freiburg, Albertstrasse 9, Freiburg D 79104, Germany
    Forensic Sci Int 144:269-83. 2004
    ..was typically to evade military service, this category of injury was later mainly seen in the context of insurance fraud; more recently most forensically relevant self-inflicted injuries refer to simulated offenses (fictitious sexual ..
  101. ncbi Ethical and quasi-ethical issues in medical editing and publishing
    R M Pitkin
    Obstetrics and Gynecology, 10921 Wilshire Boulevard, Suite 403, Los Angeles, CA 90024 3908, USA
    Croat Med J 39:95-101. 1998
    ..When fraud or plagiarism is alleged about something a journal has published, the journal is not equipped to undertake the ..

Research Grants24

  1. A Compact and Low Cost High-Precision Carbon Isotope Ratio Monitoring Tool for Ro
    Nabil Saad; Fiscal Year: 2009
    ..authentication and controls in place to ensure the safety and integrity of food, the consumer is at risk of fraud and its sometimes disastrous effects on the health and welfare of the general public...
  2. Environmental factors predictive of misbehavior in collaborative health research
    James M DuBois; Fiscal Year: 2010
    ..g., we will not focus just on fraud or narrow misconduct cases), and cases involving differing levels of collaboration...
  3. SOUTH AFRICA RESEARCH ETHICS CAPACITY BUILDING PROJECT
    Solomon Benatar; Fiscal Year: 2001
    ..of international research activities, (VII) the need for international vaccine trials, and (VIII) recent research fraud in SA...
  4. SOCIAL INFLUENCE ON MEMORY ACROSS THE ADULT LIFESPAN
    Colleen Kelley; Fiscal Year: 1999
    ..memory responses, people may experience negative consequences including increased vulnerability to deception and fraud. This could be particularly problematic for older adults who experience more memory failures or are less confident ..
  5. Quality Assurance and Data Integrity in Clinical Trials
    Yuan I Min; Fiscal Year: 2002
    ..is to examine current practices, expert opinions, and case studies to develop statistical approaches for detecting fraud and to develop guidelines for the prevention and detection of fraud in clinical trials...
  6. Michigan Health Fraud Task Force
    Ellen Marks; Fiscal Year: 2005
    ..Abstract Not Provided. ..
  7. Puerto Rico Health Fraud Task Force
    SANDRA TORRES RIVERA; Fiscal Year: 2005
    ..Abstract Not Provided ..
  8. Use of Claims Data to Study Quality of Cancer Care
    James Goodwin; Fiscal Year: 2007
    ..We will then explore the reliability of the provider-level data in order to assess its potential utility in assessing quality of care for individual providers. ..
  9. Assessing Treatment-Related Harms in Prostate Cancer
    H Welch; Fiscal Year: 2007
    ..The entire process will be repeated on a cohort of men who receive a transurethral resection of the prostate. ..
  10. SYRINGE ACCESS AND HIV RISK
    Merrill Singer; Fiscal Year: 2002
    ..g., high or low availability of sterile syringes) and actual risk factors (e.g., frequency of infected syringes in circulation). ..
  11. VARIATIONS IN BREAST CANCER TREATMENT AND MORTALITY
    James Goodwin; Fiscal Year: 2002
    ..abstract_text> ..
  12. Melanoma Chemoprevention
    Robert Dellavalle; Fiscal Year: 2006
    ..His current career goals are completing a Masters of Science in Public Health and becoming an independent researcher in skin cancer prevention and control. ..
  13. UTMB Center for Population Health and Health Disparities
    James Goodwin; Fiscal Year: 2008
    ..unreadable] [unreadable]..
  14. EFFECTS OF PARTNER VIOLENCE VICTIMIZATION IN DRUG USE
    Merrill Singer; Fiscal Year: 2002
    ....